Ergolide is primarily studied for its potential anti-inflammatory and anticancer properties. It has shown inhibitory effects on signaling pathways involved in inflammation, particularly by suppressing the activation of NF-κB, a key regulator of immune and inflammatory responses. This makes it a candidate of interest in research related to chronic inflammatory diseases. In oncology research, ergolide demonstrates cytotoxic effects against certain cancer cell lines by inducing apoptosis and inhibiting cell proliferation. Its ability to interfere with cellular redox balance and disrupt mitochondrial function contributes to its observed antitumor activity in preclinical models. Additionally, ergolide has been explored for its neuroprotective potential due to its anti-inflammatory action in neural tissues, suggesting possible relevance in neurodegenerative conditions such as Alzheimer’s disease, though research remains in early stages. Most applications are currently limited to laboratory and experimental settings, with no widespread clinical use established to date.